Commonwealth Equity Services, LLC Biomarin Pharmaceutical Inc Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 6,325 shares of BMRN stock, worth $421,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,325
Previous 7,232 12.54%
Holding current value
$421,434
Previous $595,000 25.21%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$69.02 - $93.84 $62,601 - $85,112
-907 Reduced 12.54%
6,325 $445,000
Q2 2024

Jul 31, 2024
SELL
$74.43 - $92.22 $4,316 - $5,348
-58 Reduced 0.8%
7,232 $595,000
Q1 2024

Apr 29, 2024
BUY
$83.81 - $99.0 $38,049 - $44,946
454 Added 6.64%
7,290 $637,000
Q4 2023

Feb 06, 2024
SELL
$76.22 - $98.51 $43,978 - $56,840
-577 Reduced 7.78%
6,836 $659,000
Q3 2023

Oct 23, 2023
BUY
$85.07 - $94.48 $48,319 - $53,664
568 Added 8.3%
7,413 $656,000
Q2 2023

Aug 10, 2023
BUY
$86.68 - $100.3 $57,208 - $66,198
660 Added 10.67%
6,845 $593,000
Q1 2023

May 11, 2023
BUY
$87.74 - $117.27 $64,137 - $85,724
731 Added 13.4%
6,185 $601,000
Q4 2022

Feb 07, 2023
BUY
$80.93 - $108.63 $8,902 - $11,949
110 Added 2.06%
5,454 $564,000
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $32,288 - $38,097
-393 Reduced 6.85%
5,344 $453,000
Q2 2022

Jul 19, 2022
SELL
$71.48 - $86.85 $39,528 - $48,028
-553 Reduced 8.79%
5,737 $475,000
Q1 2022

May 04, 2022
SELL
$74.28 - $92.69 $1.79 Million - $2.23 Million
-24,088 Reduced 79.29%
6,290 $484,000
Q4 2021

Jan 31, 2022
SELL
$71.72 - $91.47 $73,226 - $93,390
-1,021 Reduced 3.25%
30,378 $2.68 Million
Q3 2021

Oct 29, 2021
SELL
$74.77 - $85.47 $16,972 - $19,401
-227 Reduced 0.72%
31,399 $2.43 Million
Q2 2021

Aug 11, 2021
BUY
$75.51 - $84.79 $11,779 - $13,227
156 Added 0.5%
31,626 $2.64 Million
Q1 2021

May 04, 2021
BUY
$74.73 - $90.69 $195,418 - $237,154
2,615 Added 9.06%
31,470 $2.38 Million
Q4 2020

Feb 11, 2021
BUY
$72.61 - $90.2 $1.9 Million - $2.35 Million
26,107 Added 950.04%
28,855 $2.53 Million
Q3 2020

Nov 05, 2020
SELL
$71.87 - $131.03 $74,457 - $135,747
-1,036 Reduced 27.38%
2,748 $209,000
Q2 2020

Aug 12, 2020
BUY
$79.55 - $124.22 $26,490 - $41,365
333 Added 9.65%
3,784 $466,000
Q1 2020

May 11, 2020
BUY
$71.37 - $96.85 $29,618 - $40,192
415 Added 13.67%
3,451 $291,000
Q4 2019

Feb 05, 2020
SELL
$64.27 - $86.37 $411,970 - $553,631
-6,410 Reduced 67.86%
3,036 $256,000
Q3 2019

Oct 30, 2019
SELL
$67.4 - $85.11 $140,259 - $177,113
-2,081 Reduced 18.05%
9,446 $636,000
Q2 2019

Jul 19, 2019
BUY
$80.35 - $93.9 $30,774 - $35,963
383 Added 3.44%
11,527 $987,000
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $119,900 - $140,434
1,424 Added 14.65%
11,144 $989,000
Q4 2018

Feb 11, 2019
BUY
$80.14 - $106.07 $113,638 - $150,407
1,418 Added 17.08%
9,720 $827,000
Q3 2018

Nov 06, 2018
BUY
$93.92 - $105.72 $101,245 - $113,966
1,078 Added 14.92%
8,302 $805,000
Q2 2018

Jul 31, 2018
BUY
$76.01 - $99.03 $27,895 - $36,344
367 Added 5.35%
7,224 $681,000
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $114,174 - $136,166
1,470 Added 27.29%
6,857 $555,000
Q4 2017

Feb 12, 2018
BUY
$80.76 - $95.13 $435,054 - $512,465
5,387
5,387 $480,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email